List of Figures
List of Figures:

Figure 2?1: United States – Anesthesia Drugs Market (Million US$), 2011 – 2017
Figure 2?2: United States – Forecast for Anesthesia Drugs Market (Million US$), 2018 – 2024

Figure 3?1: United States – Anesthesia Drugs Market Share by Type (Percent), 2011 – 2017
Figure 3?2: United States – Forecast for Anesthesia Drugs Market Share by Type (Percent), 2018 – 2024
Figure 3?3: United States – General Intravenous Anesthesia Drugs Market Share (Percent), 2011 – 2017
Figure 3?4: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Percent), 2018 – 2024
Figure 3?5: United States – Local Anesthesia Drugs Market Share (Percent), 2011 – 2017
Figure 3?6: United States – Forecast for Local Anesthesia Drugs Market Share (Percent), 2018 – 2024
Figure 3?7: United States – Anesthesia Drugs Market Share by Company (Percent), 2011 – 2017
Figure 3?8: United States – Forecast for Anesthesia Drugs Market Share by Company (Percent), 2018 – 2024

Figure 4?1: United States – General Inhalation Anesthesia Drugs Market (Million US$), 2011-2017
Figure 4?2: United States – Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2018 – 2024
Figure 4?3: United States – General Intravenous Anesthesia Drugs Market (Million US$), 2011 – 2017
Figure 4?4: United States – Forecast for General Intravenous Anesthesia Drugs Market (Million US$), 2018 – 2024
Figure 4?5: United States – Local Anesthesia Drugs Market (Million US$), 2011-2017
Figure 4?6: United States – Forecast for Local Anesthesia Drugs Market (Million US$), 2018 – 2024

Figure 5?1: United States – Propofol Market (Million US$), 2011 – 2017
Figure 5?2: United States – Forecast for Propofol Market (Million US$), 2018 – 2024
Figure 5?3: United States – Benzodiazepines Class Market (Million US$), 2011 – 2017
Figure 5?4: United States – Forecast for Benzodiazepines Class Market (Million US$), 2018 – 2024
Figure 5?5: United States – Fospropofol Disodium Market (Million US$), 2011 – 2017
Figure 5?6: United States – Forecast for Fospropofol Disodium Market (Million US$), 2018 – 2024
Figure 5?7: United States – Ketamine Market (Million US$), 2011 – 2017
Figure 5?8: United States – Forecast for Ketamine Market (Million US$), 2018 – 2024
Figure 5?9: United States – Methohexital Sodium Market (Million US$), 2011 – 2017
Figure 5?10: United States – Forecast for Methohexital Sodium Market (Million US$), 2018 – 2024
Figure 5?11: United States – Pentobarbital Market (Million US$), 2011 – 2017
Figure 5?12: United States – Forecast for Pentobarbital Market (Million US$), 2018 – 2024
Figure 5?13: United States – Etomidate Market (Million US$), 2011 – 2017
Figure 5?14: United States – Forecast for Etomidate Market (Million US$), 2018 – 2024
Figure 5?15: United States – Fentanyl Market (Million US$), 2011 – 2017
Figure 5?16: United States – Forecast for Fentanyl Market (Million US$), 2018 – 2024

Figure 6?1: United States – Articaine Market (Million US$), 2011-2017
Figure 6?2: United States – Forecast for Articaine Market (Million US$), 2018 – 2024
Figure 6?3: United States – Bupivacaine Market (Million US$), 2011-2017
Figure 6?4: United States – Forecast for Bupivacaine Market (Million US$), 2018 – 2024
Figure 6?5: United States – Lidocaine Market (Million US$), 2011-2017
Figure 6?6: United States – Forecast for Lidocaine Market (Million US$), 2018 – 2024
Figure 6?7: United States – Mepivacaine Market (Million US$), 2011-2017
Figure 6?8: United States – Forecast for Mepivacaine Market (Million US$), 2018 – 2024
Figure 6?9: United States – Prilocaine Market (Million US$), 2011-2017
Figure 6?10: United States – Forecast for Prilocaine Market (Million US$), 2018 – 2024

Figure 7?1: United States – Baxter International Anesthesia Drugs Sales (Million US$), 2011-2017
Figure 7?2: United States – Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7?3: United States – Endo International plc Anesthesia Drugs Sales (Million US$), 2011-2017
Figure 7?4: United States – Forecast for Endo International plc Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7?5: United States – AbbVie Anesthesia Drugs Sales (Million US$), 2011 - 2017
Figure 7?6: United States – Forecast for AbbVie Anesthesia Drugs Sales (Million US$), 2018 – 2024
Figure 7?7: United States – Other Companies Anesthesia Drugs Sales (Million US$), 2011 – 2017
Figure 7?8: United States – Forecast for Other Companies Anesthesia Drugs Sales (Million US$), 2018 – 2024

Figure 11?1: United States – Cosmetic Procedures (Number), 1997, 2012-2013, 2015-2016
Figure 11?2: United States – Ageing Population by Age Group (Thousand), 2012 – 2016

Figure 12?1: United States – By Region Availability of Anesthesia Specialists (Percent), 2010
Figure 12?2: United States – By States Availability of Anesthesia Specialists (Percent), 2010
Figure 12?3: United States – Drugs Shortage (Number), 2001-2015
Figure 12?4: United States – Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012

 

List of Tables

Table 8?1: United States – Anesthesia Market Merger & Acquisitions (M&A), Jan 2016 – March 2017

Table 9?1: Coventry Health Care - Anesthesia Modifiers, 2016
Table 9?2: Blue Cross and Blue Shield of Texas - Physical Status Modifiers, 2017
Table 9?3: Blue Cross and Blue Shield of Texas - Qualifying Circumstances, 2017
Table 9?4: Blue Cross and Blue Shield of Texas - Modifier Information Billed by an Anesthesiologist, 2017
Table 9?5: Blue Cross and Blue Shield of Texas - Modifier Information Billed by a CRNA, 2017
Table 9?6: Blue Cross and Blue Shield of Texas - Anesthesia Modifier Reimbursement
Table 9?7: UnitedHealthcare Community – Modifiers, 2017

Table 10?1: Medicare - Reimbursement Formulas
Table 10?2: Medicare - General and Monitored Anesthesia Care
Table 10?3: Medicare - Anesthesia Modifiers, 2017
Table 10?4: MDwise –Type of Service & PA Requirement
Table 10?5: MDwise - Anesthesia Time Table, 2017
Table 10?6: MDwise - Qualifying Circumstances, 2017
Table 10?7: MDwise - Status Modifiers, 2017

Table 11?1: United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030